Home

homehealthcare NewsGlenmark to pay $48 mn to Direct Purchaser Plaintiffs in connection with Zetia generic

Glenmark to pay $48 mn to Direct Purchaser Plaintiffs in connection with Zetia generic

By Ekta Batra | Apr 19, 2023 2:41 PM IST (Updated)

Mini

In the pending antitrust and consumer protection litigation, Glenmark pharma is named as a defendant and trial for this case is scheduled to begin on April 19, 2023 in the U.S. courts. The Company has agreed to enter a settlement with the Direct Purchaser Plaintiff group and shall pay US$ 48mn to the Direct Purchasers.

healthcare | Apr 19, 2023 11:11 AM IST

There are multiple antitrust and consumer protection lawsuits, including a class action, consolidated in the Eastern District of Virginia, U.S. against the Company and its subsidiary Glenmark Pharmaceuticals Inc., USA in connection with generic Zetia, a drug for the treatment of cholesterol.